AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Dibaglim M 0.5mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Kasdap Healthcare Pvt Ltd

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview Dibaglim M 0.5mg/500mg Tablet

Glucolyn M 0.5mg/500mg tablets are classified as antidiabetic agents, a combination medication for adult type 2 diabetes management. This formulation helps regulate blood glucose in diabetic patients. Glucolyn M 0.5mg/500mg tablets should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as recommended by your doctor. Lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential to manage this risk. Alcohol consumption should be limited due to its hypoglycemic potential. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or breastfeeding individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) are usually recommended.

Uses of Dibaglim M 0.5mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Dibaglim M 0.5mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 0.5mg/500mg Dibaglim M tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Dibaglim M 0.5mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Dibaglim M 0.5mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 0.5mg/500mg Dibaglim M tablet whole; do not alter its form by chewing, crushing, or breaking. Consume this medicine with a meal.

How Dibaglim M 0.5mg/500mg Tablet works:

Each Dibaglim M 0.5mg/500mg tablet unites glimepiride (a sulfonylurea) and metformin (a biguanide), two distinct antidiabetic agents. Glimepiride stimulates pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin acts by decreasing hepatic glucose output, retarding intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Dibaglim M 0.5mg/500mg tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Dibaglim M 0.5mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Dibaglim M 0.5mg/500mg tablets are incompatible. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Dibaglim M 0.5mg/500mg tablets cautiously, potentially requiring dosage modification. Physician consultation is essential. The medication is contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Dibaglim M 0.5mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation with a reduced Dibaglim M 0.5mg/500mg tablet dosage is typical; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Dibaglim M 0.5mg/500mg Tablet :

Should you forget to take a Dibaglim M 0.5mg/500mg Tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dibaglim M 0.5mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Dibaglim M 0.5mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Dibaglim M 0.5mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Dibaglim M 0.5mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This treatment improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 DM.
Dibaglim M 0.5mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Dibaglim M 0.5mg/500mg Tablets can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and gait instability), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental Vitamin B12 is recommended by some researchers.
Dibaglim M 0.5mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Dibaglim M 0.5mg/500mg tablets with alcohol is unsafe. This combination can lower blood sugar, causing hypoglycemia, and increase the risk of lactic acidosis.
Dibaglim M 0.5mg/500mg Ta...
54
MRP 66
18% off